Dr. Kesari on Neuro-Oncology Some patients do well if given treatments in neoadjuvant
Ashkan Lashkari, MD, shares Dr. Kesari on Neuro-Oncology Some patients do well if given treatments in neoadjuvantat the 2018 Oncology Summit in Huntington Beach, CA Author: moasc Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Dr. Fakih's Talk on Colorectal Cancer Microsatellite instability is an approved biomarker
Ashkan Lashkari, MD, shares Dr. Fakih's Talk on Colorectal Cancer Microsatellite instability is an approved biomarker at the 2018 Oncology Summit in Huntington Beach, CA Author: moasc Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Dr. Hurvitzs Study on Breast Cancer Using Tumor-Infiltrating Lymphocytes as a biomarker
Ashkan Lashkari, MD, shares Dr. Hurvitzs Study on Breast Cancer Using Tumor-Infiltrating Lymphocytes as a biomarker at the 2018 Oncology Summit in Huntington Beach, CA Author: moasc Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Dr. Reckcamp Overview on Lung Cancer Combine established Immunotherapy w new therapies
Ashkan Lashkari, MD, shares Dr. Reckcamp Overview on Lung Cancer Combine established Immunotherapy with new therapies at the 2018 Oncology Summit in Huntington Beach, CA Go to: http://www.moasc.or...... Author: moasc Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Dr. Hamid On Metastatic Melanoma IDO Inhibitors can help overcome resistance
Ashkan Lashkari, MD, shares Dr. Hamid On Metastatic Melanoma IDO Inhibitors can help overcome resistance at the 2018 Oncology Summit in Huntington Beach, CA Go to: http://www.moasc.org... for more in... Author: moasc Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Dr. Powells Study On RCC & amp; Bladder Tumors Augment treatment responses with good safety signals
Ashkan Lashkari, MD, shares Dr. Powells Study On RCC & Bladder Tumors Augment treatment responses with good safety signals at the 2018 Oncology Summit in Huntington Beach, CA Author: moasc Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts

MOASC Overview - Highlights from Presentations A number of speakers talk across different tumor types
Ashkan Lashkari, MD, gives a MOASC Overview - Highlights from Presentations A number of speakers talk across different tumor types at the 2018 Oncology Summit in Huntington Beach, CA Go to: http:/... Author: moasc Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Looking Forward to Mature Data on Glioblastoma Updates from Antibody-based trials
Santosh Kesari, MD, explains Looking Forward to Mature Data on Glioblastoma Updates from Antibody-based trials at the 2018 Oncology Summit in Huntington Beach, CA Go to: http://www.moasc.org... for m... Author: moasc Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Patients May Benefit from Molecular Profiling of Tumor BRAF, PI3K, etc, would benefit from available drugs
Santosh Kesari, MD, explains Patients May Benefit from Molecular Profiling of Tumor BRAF, PI3K, etc, would benefit from available drugs at the 2018 Oncology Summit in Huntington Beach, CA Go to: ... Author: moasc Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Immunotherapy Can have Activity in the Brain Do better at managing toxicities
Santosh Kesari, MD, discusses how Immunotherapy Can have Activity in the Brain Do better at managing toxicities at the 2018 Oncology Summit in Huntington Beach, CA Go to: http://www.moasc.org... fo... Author: moasc Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Immunotherapy in Glioma Study in the neoadjuvant setting
Santosh Kesari, MD, Immunotherapy in Glioma Study in the neoadjuvant setting at the 2018 Oncology Summit in Huntington Beach, CA Go to: http://www.moasc.org... for more information Author: moasc Added: 03/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Identify Who Can Take Immunotherapy in the First-Line The durability of responses would be much better
Marwan Fakih, MD, explains Identify Who Can Take Immunotherapy in the First-Line The durability of responses would be much better at the 2018 Oncology Summit in Huntington Beach, CA Go to: http:/... Author: moasc Added: 03/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 9, 2018 Category: Cancer & Oncology Source Type: podcasts

Presented Data has Affected Day-to-Day Practice Has already been affecting MSI-High patients
Marwan Fakih, MD, shares Presented Data has Affected Day-to-Day Practice Has already been affecting MSI-High patients at the 2018 Oncology Summit in Huntington Beach, CA Go to: http://www.moasc.o...... Author: moasc Added: 03/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 9, 2018 Category: Cancer & Oncology Source Type: podcasts

Disappointing Data for Patients without MSI Great responses to checkpoint inhibitors
Marwan Fakih, MD, explains Disappointing Data for Patients without MSI Great responses to checkpoint inhibitors at the 2018 Oncology Summit in Huntington Beach, CA Go to: http://www.moasc.org... for ... Author: moasc Added: 03/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 9, 2018 Category: Cancer & Oncology Source Type: podcasts

Microsatellite Instability in Colorectal Cancer PD-1 Inhibitors have a significant response rate
Marwan Fakih, MD, explains Microsatellite Instability in Colorectal Cancer PD-1 Inhibitors have a significant response rate at the 2018 Oncology Summit in Huntington Beach, CA Go to: http://www.mo...... Author: moasc Added: 03/08/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 9, 2018 Category: Cancer & Oncology Source Type: podcasts

Stage III Lung Cancer Receptible vs. Unreceptible
Karen Reckamp, MD, MS Medical Director, Clinical Research Operationsshares Stage III Lung Cancer Receptible vs. Unreceptible at the 2018 Oncology Summit in Huntington Beach, CA Go to: http://www...... Author: moasc Added: 03/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 7, 2018 Category: Cancer & Oncology Source Type: podcasts

Refine Patient Subsets & Define Combinations
Karen Reckamp, MD, MS Medical Director, Clinical Research Operationsexplains Refine Patient Subsets & Define Combinations at the 2018 Oncology Summit in Huntington Beach, CA Go to: http://www.m...... Author: moasc Added: 03/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 7, 2018 Category: Cancer & Oncology Source Type: podcasts

Immunotherapy in Melanoma: Whats up next?
Omid Hamid MD Chief, Translational Research/Immuno-OncologyDirector presents, Immunotherapy in Melanoma at the 2018 Oncology Summit in Huntington Beach, CA Go to: http://www.moasc.org... for more... Author: moasc Added: 03/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 6, 2018 Category: Cancer & Oncology Source Type: podcasts

The Role of Immunotherapy in Breast Cancer
Sara A Hurvitz, MD, FACP Associate Professor of Medicine Director, Breast Oncology, examines The Role of Immunotherapy in Breast Cancer at the 2018 Oncology Summit in Huntington Beach, CA Author: moasc Added: 03/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Investigating the Tumor Immune Response to Optimize Treatment in Colorectal Cancer
Marwan Fakih, MD, explains Investigating the Tumor Immune Response to Optimize Treatment in Colorectal Cancer at the 2018 Oncology Summit in Huntington Beach, CA Go to: http://www.moasc.org... for mo... Author: moasc Added: 03/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Harnessing the Power of ImmunotherapyLung Cancer
Karen Reckamp, MD, MS Medical Director, Clinical Research Operations provides an in-depth look at Harnessing the Power of ImmunotherapyLung Cancer in the 2018 Oncology Summit in Huntington Beach, CA ... Author: moasc Added: 03/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 6, 2018 Category: Cancer & Oncology Source Type: podcasts

Lung Cancer Immunotherapy Advances PDL-1 and Tumor Mutational Burden
Karen Reckamp, MD, MS Medical Director, Clinical Research Operations shares Lung Cancer Immunotherapy Advances PDL-1 and Tumor Mutational Burden at the 2018 Oncology Summit in Huntington Beach, CA ... Author: moasc Added: 03/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 6, 2018 Category: Cancer & Oncology Source Type: podcasts

MOASC Oncology Summit Kick Off
March 3rd, 2018. Dr. Warren H. Fong, MD MOASC President kicks off the 2018 Oncology Summit in Huntington Beach, CA with Ashkan Lashkani, MD Program Director and keynote ... Author: moasc Added: 03/03/2018 (Source: Oncology Tube)
Source: Oncology Tube - March 3, 2018 Category: Cancer & Oncology Source Type: podcasts

Positive Data for RR-CLL Patients Able to see MRD Negativity at month 6
Dr. Ann Eapen Division of Hematology/Oncology: UC Irvine discusses Positive Data for RR-CLL Patients Able to see MRD Negativity at month 6 at MOASCs Spotlight On Hematology in Huntington Beach 2018. ... Author: moasc Added: 02/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 7, 2018 Category: Cancer & Oncology Source Type: podcasts

JAK Inhibitors are a Central Theme in MPN Lots of JAK Inhibitors being tested in clinical trials
Angela Fleischman MD PhD UC Irvine discusses JAK Inhibitors are a Central Theme in MPN Lots of JAK Inhibitors being tested in clinical trials at MOASCs Spotlight On Hematology in Huntington Beach 201... Author: moasc Added: 02/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 7, 2018 Category: Cancer & Oncology Source Type: podcasts

Preventing Progress of MPN Presently this area is limited and needs to be focused on
Angela Fleischman MD PhD UC Irvine discusses Preventing Progress of MPN Presently this area is limited and needs to be focused on at MOASCs Spotlight On Hematology in Huntington Beach 2018. Author: moasc Added: 02/06/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 7, 2018 Category: Cancer & Oncology Source Type: podcasts

Update MDS and Nonmalignant Heme
Kanwarpal Kahlon, MD, from Ronald Reagan UCLA Medical Center talks about updates on Myelodysplastic syndrome and nonmalignant hemetology at MOASCs Spotlight On Hematology in Huntington Beach. Author: moasc Added: 02/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 2, 2018 Category: Cancer & Oncology Source Type: podcasts

Updates in Myeloproliferative Neoplasm
Angela Fleischman, MD, from UC Irvine joins us at MOASCs Spotlight On Hematology in Huntington Beach to discusses the updates in myeloproliferative neoplasm, abstracts from ASH 2017 and papers that a... Author: moasc Added: 02/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 2, 2018 Category: Cancer & Oncology Source Type: podcasts

Highlights of ASH 2017: Acute Myeloid Leukemia
Deepa Jeyakumar, MD, from UC Irvine Health discusses the Acute myeloid leukemia highlights from ASH 2017 at MOASCs Spotlight On Hematology in Huntington Beach. Author: moasc Added: 02/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 2, 2018 Category: Cancer & Oncology Source Type: podcasts

Highlights of ASH 2017 Lymphomas
Elizabeth Brm, MD, from The Chao Comprehensive Cancer Center joins us at MOASCs Spotlight On Hematology in Huntington Beach to present some of the highlights of ASH 2017 Lymphomas. Author: moasc Added: 02/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 2, 2018 Category: Cancer & Oncology Source Type: podcasts

Initial Results of the Phase 2 Treatment Naive Cohort in a Phase 1b/2 Study of Obinutuzumab, Ibrutinib, and Venetoclax in CLL
Miguel Risco, MD, from UC-Irvine Department of Hematology and Oncology joins us at MOASCs Spotlight On Hematology in Huntington Beach to present "Initial Results of the Phase 2 Treatment Naive Cohor... Author: moasc Added: 02/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 1, 2018 Category: Cancer & Oncology Source Type: podcasts

Safety of Chronic Lymphocytic Leukemia Combination Therapy - Fair Number of Hematologic & Non-Hematologic Adverse Effects
Miguel Risco, MD, from UC-Irvine Department of Hematology and Oncology joins us at MOASCs Spotlight On Hematology in Huntington Beach to talk about the safety of chronic lymphocytic leukemia combina... Author: moasc Added: 02/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 1, 2018 Category: Cancer & Oncology Source Type: podcasts

Toxicities with IDH1 & IDH2 Inhibitors - IDH Differentiation Syndrome is a new side-effect
Deepa Jeyakumar, MD, from UC Irvine Health For Multiple Myeloma Research joins us at MOASCs Spotlight On Hematology in Huntington Beach to discuss the toxicities with IDH1 & IDH2 inhibitors and a ne... Author: moasc Added: 02/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 1, 2018 Category: Cancer & Oncology Source Type: podcasts

Strategies for Treating Relapsed Myeloma - Daratumumab with IMiDs, Venetoclax, Transplants
Amrita Krishnan, MD, from The Judy and Bernard Briskin Center For Multiple Myeloma Research joins us at MOASCs Spotlight On Hematology in Huntington Beach to discuss different strategies for treatin... Author: moasc Added: 02/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 1, 2018 Category: Cancer & Oncology Source Type: podcasts

Trials in Combination Therapy for CLL - Phase 2 Trial results with Obinutuzumab, Ibrutunib, & Venetoclax
Miguel Risco, MD, from UC-Irvine Department of Hematology and Oncology joins us at MOASCs Spotlight On Hematology in Huntington Beach to discuss the trials in combination therapy for Chronic Lymphoc... Author: moasc Added: 02/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 1, 2018 Category: Cancer & Oncology Source Type: podcasts

Tandem Transplantation in Multiple Myeloma - Phase 3 Trial showed patients had a progression free survival benefit
Amrita Krishnan, MD, from The Judy and Bernard Briskin Center For Multiple Myeloma Research joins us at MOASCs Spotlight On Hematology in Huntington Beach to talk about the tandem transplantation in... Author: moasc Added: 02/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 1, 2018 Category: Cancer & Oncology Source Type: podcasts

Drugs to Use if One has Cancer or Clots - Rivaroxaban, Apixaban, Edoxaban are effective oral drugs
Kanwarpal Kahlon, MD, from Ronald Reagan UCLA Medical Center joins us at MOASCs Spotlight On Hematology in Huntington Beach to discuss the effective oral drugs to use (Rivaroxaban, Apixaban, Edoxaba... Author: moasc Added: 02/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 1, 2018 Category: Cancer & Oncology Source Type: podcasts

Bluebird Trial BCMA CAR-T on 24 Patients - Over half of patients getting complete remissions
Amrita Krishnan, MD, from The Judy and Bernard Briskin Center For Multiple Myeloma Research joins us at MOASCs Spotlight On Hematology in Huntington Beach to talk about the Bluebird trial BCMA CAR-T... Author: moasc Added: 02/01/2018 (Source: Oncology Tube)
Source: Oncology Tube - February 1, 2018 Category: Cancer & Oncology Source Type: podcasts

Neratinib and Capecitabine for Patients with HER2+ Breast Cancer Brain Metastases (BCBM)
Daniela Bota, MD of UC Irvine Health discusses the use of neratinib and capecitabine in patients with breast cancer brain metastases at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beac... Author: moasc Added: 08/03/2017 (Source: Oncology Tube)
Source: Oncology Tube - August 3, 2017 Category: Cancer & Oncology Source Type: podcasts

Nivolumab versus Nivolumab Combined with Ipilimumab in Patients with Melanoma Brain Metastases
Daniela Bota, MD of UC Irvine Health discusses the results of nivolumab versus nivolumab plus ipilimumab in patients with Melanoma at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beach,... Author: moasc Added: 08/03/2017 (Source: Oncology Tube)
Source: Oncology Tube - August 3, 2017 Category: Cancer & Oncology Source Type: podcasts

ARCHER 1050: Dacomitinib versus Gefitinib in EGFR+ NSCLC
Viola Zhu, MD, PhD of UC Irvine Health gives an overview of the ARCHER 1050 trial in EGFR+ non-small cell lung cancer at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beach, CA. Abst... Author: moasc Added: 08/02/2017 (Source: Oncology Tube)
Source: Oncology Tube - August 2, 2017 Category: Cancer & Oncology Source Type: podcasts

Take-Home Message of PALOMA-1
Rita Mehta, MD of UC Irvine Health discusses the take-home message of PALOMA-1 and the impact on clinical practice at the 2017 MOASC Spotlight on Oncology in Huntington Beach, CA.Abstract 1001: Ov... Author: moasc Added: 08/02/2017 (Source: Oncology Tube)
Source: Oncology Tube - August 2, 2017 Category: Cancer & Oncology Source Type: podcasts

Sidedness of Tumors in Metastatic Colorectal Cancer
Farshid Dayyani, MD, PhD of UC Irvine Health discusses sidedness in colorectal cancer tumors at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beach, CA. Author: moasc Added: 08/02/2017 (Source: Oncology Tube)
Source: Oncology Tube - August 2, 2017 Category: Cancer & Oncology Source Type: podcasts

Overview of the IDEA Trial in Colorectal Cancer
Farshid Dayyani, MD, PhD of UC Irvine Health gives an overview of the IDEA trial at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beach, CA. Author: moasc Added: 08/02/2017 (Source: Oncology Tube)
Source: Oncology Tube - August 2, 2017 Category: Cancer & Oncology Source Type: podcasts

The Immunotherapy Trials in Gastroesophageal Carcinomas
Farshid Dayyani, MD, PhD of UC Irvine Health discusses the Immunotherapy Trials, the Keynote trial and the Checkmate trial, at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beach, CA. Author: moasc Added: 08/02/2017 (Source: Oncology Tube)
Source: Oncology Tube - August 2, 2017 Category: Cancer & Oncology Source Type: podcasts

Multiple Myeloma Update from ASCO 2016
Kanwar Kahlon, MD Assistant Clinical Professor, Department of Medicine gives a Multiple Myeloma Update from ASCO 2016 at the MOASC Spotlight on ASCO event in Huntington Beach, CA Author: moasc Added: 07/16/2016 (Source: Oncology Tube)
Source: Oncology Tube - July 17, 2016 Category: Cancer & Oncology Source Type: podcasts

Who's practicing euthanasia and physician-assisted suicide?, clopidogrel for secondary prevention of stroke, a new treatment for Huntington disease, and more
Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the July 05, 2016 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - July 5, 2016 Category: Journals (General) Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts

February 9 2016 Issue
1) Mid-life milk consumption and substantia nigra neuron density at death2) What's Trending: Interview with Dr. Ray Dorsey about new Neurology site, which will be called Innovations in Care Delivery3) Topic of the month: Neurology Today story about should there be a moratorium on human germline editingThis podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Binit Shah interviews Dr. Robert Abbott about his paper on mid-life milk consumption and substantia nigra neuro density at death....
Source: Neurology Podcast - February 8, 2016 Category: Neurology Authors: American Academy of Neurology Source Type: podcasts

February 9 2016 Issue
1) Mid-life milk consumption and substantia nigra neuron density at death2) What's Trending: Interview with Dr. Ray Dorsey about new Neurology site, which will be called Innovations in Care Delivery3) Topic of the month: Neurology Today story about should there be a moratorium on human germline editingThis podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Binit Shah interviews Dr. Robert Abbott about his paper on mid-life milk consumption and substantia nigra neuro density at death....
Source: Neurology Podcast - February 8, 2016 Category: Neurology Authors: American Academy of Neurology Source Type: podcasts